[1]
|
Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis[J]. Am J Respir Crit Care Med(4 Pt 1), 2000, 162:1277-1284. |
[2]
|
成人支气管扩张症诊治专家共识编写组. 成人支气管扩张症诊治专家共识[J].中华结核和呼吸杂志, 2012, 35(7):485-492. |
[3]
|
Boothby LA, Doering PL. FDA labeling system for drugs in pregnancy[J]. Ann Pharmacother, 2001, 35(11):1485-1489. |
[4]
|
Dombrowski MP, Schatz M. ACOG practice bulletin:clinical management guidelines for obstetrician-gynecologists number 90, February 2008, asthma in pregnancy[J]. Obstet Gynecol, 2008, 111(2Pt1):457-464. |
[5]
|
National Heart, Lung and Blood Institute, National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy:recommendations for pharmacologic treatment-2004 update[J]. J Allergy Clin Immunol, 2005, 115(1):34-46. |
[6]
|
宋宁, 侯迎秋, 张聪敏. 妊娠期支气管哮喘控制药物的应用[J]. 国际呼吸杂志, 2008,28(11):692-695. |
[7]
|
Enriquez R, Griffin MR, Carroll KN, et al. Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes[J]. J Allergy Clin Immunol, 2007, 120(3):625-630. |
[8]
|
Gluck JC, Gluck PA. Asthma controller therapy during pregnancy[J]. Am J Obstet Gynecol, 2005, 192(2):369-380. |
[9]
|
陈岷, 李延. 妊娠期合并哮喘的药物治疗[J]. 世界临床药物, 2008, 29(7):418-421. |
[10]
|
Lenfant C, Khaltaev N. Global initiative for chronic obstructive lung disease[M]. Maryland:NIH Publication, 2001:65-86. |
[11]
|
蒋雷服, 殷凯生, 黄茂. 妊娠期支气管哮喘治疗进展[J]. 国际呼吸杂志, 2010,30(11):689-692. |